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Confocal laser endomicroscopy (CLE) is a novel, noninvasive technique used to obtain microanatomical
images of the inner lining of hollow organs. It has been used in a variety of clinical specialties to aid in the
diagnosis and treatment planning of inflammatory and neoplastic processes. Our intent is to provide an
up-to-date review of the literature in the setting of head and neck diseases as well as describing our own
initial results and areas of future research.
Recent findings
With increasing experience using CLE in the upper aerodigestive tract (UADT), evidence is mounting that
this method can be a useful adjunct to standard endoscopy and other diagnostic techniques. Recent
publications have shown that by using CLE, microanatomical structures of healthy and diseased mucosa
can easily be identified, allowing for a differentiation of dysplastic/neoplastic and benign mucosal lesions.
Standardized diagnostic protocols as well as clinically relevant classification systems for the UADT have not
yet been described.
Summary
CLE is an imaging modality that allows real-time visualization of mucosal cellular architecture and other
histologic characteristics. First reports on its use in the UADT have yielded promising results, but the true
value of this method is yet to be determined.
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Endoscopic examination followed by invasive tissue
biopsy is the current gold standard in the evaluation
of lesions of the upper aerodigestive tract (UADT). In
more diffuse or widespread lesions, over or under-
treatment is possible when their extent is not clearly
identifiable. Therefore, novel optical techniques
have been developed to reveal in-situ information
about the histologic characteristics of tissues.
Confocal laser endomicroscopy (CLE) is one of
the techniques that has found its way into routine
clinical use in gastroenterology and its further appli-
cation is currently under investigation in other
fields. CLE allows high-resolution, microanatomical
analysis of tissue (’optical biopsies’) in real time
during endoscopy [1,2]. The utility of this new
technology is highlighted by its capacity to differ-
entiate tissue types and entities on the basis of
histologic characteristics of the mucosa and sub-
mucosal vasculature [3]. These findings could
serve to reduce unnecessary biopsies and identify
lesions needing further treatment. Moreover, byams & Wilkins. Unauthodetermining the exact extent of lesions, a more
precise treatment can be rendered and unwanted
effects from over and underresection minimized.TEXT OF REVIEW
In the following, a brief technical background is
provided on CLE, it is compared with other novel
diagnostic methods, and relevant clinical appli-
cations in the head and neck field are presented.rized reproduction of this article is prohibited.
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KEY POINTS
 Confocal laser scanning endomicroscopy (CLE) is a
noninvasive, high-resolution imaging method for the
endoscopic examination of the most superficial tissue
layers in vivo.
 There are two commercially available CLE systems on
the market, which work with intravenous fluorescein as
a contrast agent.
 CLE has become a diagnostic adjunct to endoscopic
examination in the diagnostic workup of Barrett’s
oesophagus and colorectal neoplasms.
 Although still on a low level of evidence, CLE seems to
be helpful to differentiate normal mucosa from
dysplastic/early invasive epithelial lesions of the UADT.
Confocal laser endomicroscopy in head and neck Volgger et al.Technical background
Confocal microscopy was first described in 1955, but
only when the concept was further developed some
20 years later did the first confocal microscopes
become commercially available [4].
Confocal laser scanning microscopy (CLSM)
provides high-resolution images by scanning a laser
focus laterally across a sample and collecting induced
fluorescence or (less commonly) reflectance whilst
rejecting all out-of-focus light by a pinhole in front of
the detector (Fig. 1). With high numerical aperture
objectives, submicron resolution can be achieved
in all planes. CLE transfers these principles into a
miniaturized endoscopic version [5
&
].
In CLE, two-dimensional tissue scanning is
possible at speeds up to video rate and down to a






FIGURE 1. Setup of a confocal (endo)microscope.
1068-9508  2013 Wolters Kluwer Health | Lippincott Williams & Wilk250 mm. In contrast to the cross-sectional orientation
of histological slides, CLE images are oriented parallel
to the tissue surface (’en face’ images). Due to the
miniaturization, there are tradeoffs between resol-
ution, field of view and probe size. Nevertheless,
lateral and axial resolutions to 0.5 and 3 mm, respec-
tively, fields of view as large as 800450 mm and
probe diameters to 1.0 mm have been achieved [5
&
].
Confocal imaging usually relies on tissue fluor-
escence, requiring the administration of a fluor-
escent dye to achieve sufficient morphological
contrast. The brightness of the resulting image
thereby corresponds to the intensity of detected
fluorescence.Comparison of confocal laser
endomicroscopy with other optical diagnostic
imaging methods
In order to put the method into context for the
clinician, the diagnostic capabilities of CLE are com-
pared with those of conventional and other non-
invasive optical diagnostic imaging methods. In this
review, methods evaluating the tissue surface only
are differentiated from sectional imaging tech-
niques. As all techniques provide different infor-
mation, they should be viewed to complement,
and not exclude, each other.
Optical diagnostic techniques evaluating
the tissue surface
Autofluorescence imaging (AFI) is based on two-
dimensional imaging of fluorescence emitted to
the surface by the main tissue fluorophores. It is
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Head and neck oncologyallows tissue-specific diagnosis. In enhanced fluor-
escence imaging (EFI), tumour-specific fluorophores
are exogenously applied to enhance the contrast. In
the UADT, both AFI and EFI have been shown to be a
highly sensitive, yet unspecific adjunct to regular
endoscopy that highlights and delineates patho-
logic mucosal changes [6,7].
By filtering the illumination in small bands,
narrow band imaging (NBI) highlights the super-
ficial mucosal microvasculature. According to vari-
ous trials, NBI seems to be another sensitive adjunct
method for early detection of dysplasia and cancer
in the UADT [8–10].
Sectional imaging methods
Optical coherence tomography (OCT) devices
measure the intensity of backscattered light from
within the tissue, producing cross-sectional images
similar to ultrasound B-scans [11]. For intraluminal
applications (e.g. UADT), flexible OCT probes pro-
vide resolutions on the order of 10 mm and penetra-
tion depths of 2 mm into soft tissues. The
predominant diagnostic feature is the recognition
of the integrity of the basement membrane, identi-
fying early invasive lesions by the loss of contrast
between the epithelial and connective tissue layers
with a high sensitivity [12–14].
Photo-acoustic imaging (PAI) is a hybrid biomed-
ical imaging method that can overcome limitations
in tissue penetration of other optical methods [15].
Short laser pulses induce thermoelastic expansions
within tissue structures that have absorbed the
pulses. The propagating sound waves can then be
detected, and images to a depth of 5 cm and a resol-
ution of 50 mm can be generated. Even though PAI
seems well suited for diagnostic use in the UADT, no
such attempts have been published thus far.
Figure 2 provides an overview of the various sec-





















FIGURE 2. Comparative characteristics of sectional optical
techniques and conventional imaging methods used for
diagnosis of premalignant and malignant changes in the
upper aerodigestive tract.
166 www.co-otolaryngology.comtechniques with respect to their penetration depth
and resolution.
Fluorescent contrast agents for confocal
laser endomicroscopy
To date, various fluorescent dyes with different
staining characteristics have been used in clinical
and experimental settings.
The only licensed contrast agent for use with
CLE is intravenously applied fluorescein. The
optimal dose for obtaining high-quality images (of
the colon) seems to be 5 ml of a 10% sodium fluor-
escein solution [16], but body weight adapted dos-
ing is being discussed [17]. The contrast agent
quickly diffuses across capillaries and highlights
both blood vessels and interstitial spaces for up to
30 min; however, the image quality deteriorates
after 8 min [18]. Serious adverse events such as acute
hypotension or anaphylaxis are rare [19,20]. A larger
analysis showed mild adverse reactions in 1.4%, but
no serious adverse events [21
&
].
Intracellular as well as nuclear staining of the
uppermost mucosa can be achieved by using topical
contrast agents. They are easily applied and do not
regularly carry the risk of systemic side effects, yet no
agent is officially licensed for in-vivo use in humans
and they typically do not penetrate deeply into the
mucosa [3]. The most commonly used agent is
acriflavine [22–24], which stains the nuclei and is
typically applied as acriflavine hydrochloride
0.05%. By combining fluorescein and topical
acriflavine, it is possible to calculate nuclear cyto-
plasmatic ratios, which is a useful indicator for
cellular differentiation. However, there is a consider-
able concern about a potential mutagenic effect,
which has limited its use in humans [25].
Other topical dyes (or precursors) that have been
used for CLE are cresyl violet, hypericin, 5-amino-
levulinic acid, topical fluorescein and 2-NBDG
(2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-
deoxyglucose) [26–30].
Apart from these nonspecific stains, fluorescing
probes directed against certain disease-specific bio-
markers are being investigated in experimental set-
tings [1]. The successful use of mAbs targeted against
the epidermal growth factor receptor (EGFR) or
vascular endothelial growth factor (VEGF) has been
reported in organ cultures, tissue samples and
human tumours grown in mice [31–33]. This might
help to target high-risk lesions during endoscopy
and to predict response to targeted treatment [33].Clinically certified systems
Currently, there are two clinically certified, Com-
munauté Européenne (CE)-marked and Food andrized reproduction of this article is prohibited.
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Confocal laser endomicroscopy in head and neck Volgger et al.Drug Administration (FDA)-approved CLE systems
on the market.
One of them is the ISC 100 Endomicroscope
(Pentax Life Care, Tokyo, Japan, and Optiscan Pty
Ltd., Noting Hill, Victoria, Australia). The CLE system
is integrated into the distal tip of a conventional,
large bore, flexible endoscope; this type of system is
referred to as an endoscope-based confocal laser
endomicroscope (eCLE). The Pentax system provides
continuous scanning depths from 0 to 250 mm [8],
has an excellent lateral resolution of 0.7 mm and a
fixed field of view of 475475 mm [5&].
The other system is a probe-based CLE (pCLE)
system called Cellvizio (Mauna Kea Technologies,
Paris, France). A variety of miniprobes with variable
diameters and optical characteristics can be inserted
through the working channels of any standard
endoscope. In contrast to the Pentax system, the
focal plane of each confocal miniprobe is fixed.
The optical characteristics of both systems are
compared in Table 1. Both devices function at an
excitation of 488 nm and have a detection band-
width in the upper visible range. Advantages of the
Pentax system are a higher resolution and a variable
penetration depth. Disadvantages are the large
diameter and the inflexible distal tip, limiting its
utility in confined anatomical areas [22]. The dis-
advantages of the probe-based system include a
limited lifespan of 20 procedures per miniprobe,
which increases the maintenance costs. Advantages
are the faster image acquisition rate (12 versus
0.8–1.6 frames/s) and the mosaic function, where
single images are stitched together.
According to Optiscan, a third commercial CLE
system – built into a rigid endoscope – is currently
being developed in cooperation with Carl Zeiss
Meditec AG (Jena, Germany), and FDA and
CE-clearance is targeted in mid-2013.
Clinical applications
By far, most clinical studies on CLE have been pub-
lished in gastroenterology. Hallmark indicationsCopyright © Lippincott Williams & Wilkins. Unaut




Probe/endoscope diameter (mm) 2.6 (probe) 2.7 (pro
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Lateral resolution (mm) 3.5 1
Field of view (mm) Ø 600 Ø 240
UHD, Ultra High Definition.
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interobserver reliabilities are the differentiation of
Barrett’s dysplastic lesions from nondysplastic
mucosa in the oesophagus [26] and the detection
of colorectal neoplasms, especially in follow-up situ-
ations [34]. Furthermore, CLE has been successfully
studied to evaluate hepatobiliary strictures, gastric
cancer, celiac disease and inflammatory bowel dis-
ease. For most indications, classification systems
have been defined that help to evaluate the obtained
results. Furthermore, the American Medical Associ-
ation has recently approved three CPT (current pro-
cedural terminology) codes to cover the use ofCLE for
the observation of intestinal mucosa during endo-
scopic procedures. This will facilitate the reimburse-
ment process in the USA and may lead to more
widespread acceptance and use of this technology.
Further fields with significant scientific output
on CLE are pulmonology, urology and gynaecology.
In pulmonology, CLE has been used for early detec-
tion of neoplastic changes in the bronchial tree with
a high accuracy (91.0%) [24]. In urology, marked
differences in microanatomical structures have been
reported for normal urothelium and high-grade
tumours [35], and diagnostic criteria to facilitate
interpretation of CLE images have been defined
[36]. A prospective study in gynaecology revealed
good results with a sensitivity for the detection of
cervical intraepithelial neoplasia (CIN) of 97% [37].
Compared with other fields, literature on CLE in
the context of head and neck cancer is sparse. Its use
was first described in 2004 using Protoporphyrin IX
(PPIX) as a fluorescent marker in three patients with
squamous cell carcinoma (SCC) of the tongue, and
the findings were compared with healthy mucosa
[28]. Using a prototype-rigid CLE system by Optis-
can Pty Ltd, the authors noted a higher rate of PPIX
synthesis and increases in cellular size and density in
cancerous lesions compared with normal mucosa.
In 2007, Thong et al. [38] used the same system on
normal oral mucosa and SCC in humans and in a
murine model. They used PPIX and fluorescein ashorized reproduction of this article is prohibited.
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FIGURE 3. In-vivo probe-based confocal laser endo-
microscopy (CellVizio, Mauna Kea Technologies, Paris,
France) with fluorescein (2.5 ml of a 10% solution; Alcon
GmbH, Freiburg, Germany) of normal squamous epithelium
at the left posterior vocal cord (left panel) and microinvasive
squamous cell carcinoma at the left anterior vocal cord (right
panel) in a 72-year-old, male patient.
Head and neck oncologycontrast agents, and determined that CLE with both
stains seems suitable to distinguish between normal
and dysplastic/cancerous tissue.
Following several ex-vivo studies using CLSM
for the differentiation of UADT lesions, a group from
Rice University (Houston, Texas, USA) published a
preliminary report on the use of a prototype pCLE
system working in reflectance mode on eight
patients with oral SCC in 2008 [39]. Using acetic
acid for contrast enhancement, nuclear morphology
distinctly differed for normal mucosa and cancerous
lesions.
From 2009 onwards, a group from the Institut
Gustave Roussy in Villejuif, France (M. Abbaci et al.),
have repeatedly presented their ex-vivo research on
human UADT cancers using the Cellvizio system at
various international platforms, but without having
put out citable publications. On the basis of more
than 100 fresh specimens and using a variety of
morphological (fluorescein, acriflavine, cresyl
violet, methylene blue, toluidine blue), functional
(2-NBDG) and molecular (fluorescent EGFR anti-
body) stains, they were able to discern dysplastic/
cancerous lesions from normal controls. The fea-
tures that determined (pre)-malignancy were visible
after morphological staining and included changes
in nuclear sizes and shapes, changes in nuclear
cytoplasmic ratio and disorders of keratinization;
the preliminary results of functional and molecular
staining were more inconsistent. The authors also
determined a high degree of correlation (sensi-
tivities 92–97%, specificities 85–97%) when com-
paring CLE images (dually stained with fluorescein
and acriflavine) and conventional H&E slides in
blinded evaluations.
In recent years, a clinical group from Mainz/
Wiesbaden in Germany published two preliminary
reports on the use of the Pentax eCLE system with
intravenous fluorescein in 18 patients with SCC of
the UADT [40,41
&
]. In SCC, they were able to visual-
ize neo-angiogenesis, irregular cellular architecture
and poorly defined cell borders. In addition, they
used acriflavine in ex-vivo specimens and demon-
strated differences in nuclear morphology and rates
of mitoses in normal and dysplastic specimens.
Despite these promising findings, they experienced
difficulties in the proper placement of the endo-
scope in the UADT, and initially in interpreting
the obtained images (learning curve).
In the early 2000s, Just et al. [42] had published
on the use of CLSM for different pathologic states
of the UADT. Being hindered by the bulkiness
of the system, they have recently developed a
prototype rigid CLE system and have applied it in
a murine UADT cancer model and in selected
human laryngeal diseases in vivo [42,43]. In 58 micepyright © Lippincott Williams & Wilkins. Unautho
168 www.co-otolaryngology.comwith various states of dysplasia, they were able to
differentiate low/moderate from high-grade dyspla-
sia with a sensitivity of 73% and a specificity of 88%,
and a moderate interobserver agreement of k equal
to 0.59. In volume scans of human vocal cords, they
were able to show typical features of normal and
pathologic states.
Again in 2012, Thong et al. [44] expanded upon
their prior study [38] and developed a prototype
endomicroscope-embedded computing system for
3-D visualization of tissue. This was applied in a
murine model and subsequently in healthy volun-
teers, in whom certain UADT regions were
examined following topical application of hypericin
or fluorescein. Impressively, their setup produced
high-quality 3-D renderings of filiform papillae and
cellular mucosal structures at video rates.
In an initial, unpublished pilot study, our own
group looked at dysplastic/early invasive lesions and
normal mucosa (nine subsites of the UADT) in 10
patients and five healthy volunteers using the Cell-
vizio system after intravenous application of 2.5-ml
fluorescein. Supported by an oral pathologist, we
managed to visualize tissue architecture at a subcel-
lular level, thus allowing us to differentiate normal
and neoplastic mucosa. Due to the contrast agent
applied, these distinctions were mostly based on
changes in cellular sizes and shapes (Fig. 3).
Epithelial definition of normal mucosa appeared
to be of highest quality when imaging was per-
formed against a rigid backdrop such as in the hard
palate and alveolar ridge. Currently, we anticipate torized reproduction of this article is prohibited.
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Confocal laser endomicroscopy in head and neck Volgger et al.intensify our research activities by launching a pro-
spective clinical trial to better define the role of this
method in the diagnosis of primary superficial
mucosal lesions and an ex-vivo study on human
tissue specimens comparing various stains as for
their usefulness and applicability in the UADT.CONCLUSION
CLE is a promising new, noninvasive diagnostic
method providing microanatomical images of
superficial tissue layers in vivo. The method has
established itself in gastroenterology, but numbers
of publications in other fields are on the rise. In the
UADT, CLE has shown promising results for the
differentiation of normal mucosa and dysplastic/
microinvasive lesions, but the described methods
and the results are hardly comparable. The method
has its limitations: in the vertical assessment of
tissue changes and because of a rather significant
learning curve associated with image interpretation.
Further studies are needed to better define the role of
CLE in the UADT by standardizing diagnostic pro-
tocols concerning the type of system (pCLE or eCLE)
and contrast agent (unspecific or targeted) used and
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